The AV dosing was vornoprazan 20mg twice daily and amoxicillin 750mg four times daily; BAV addedtripotassium dicitrato ...
In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other ...
GSK presented positive phase 2 results for its investigational mRNA seasonal influenza vaccine candidate at the OPTIONS XIII ...
The agency also cleared multiple updated COVID-19 vaccines for 2026-2027 targeting the XFG variant ahead of the fall ...
JAMA published the 2026-2027 immunization data for RSV, influenza, and COVID-19 including vaccine effectiveness and safety.
In a randomized trial of 840 preschoolers with moderate-to-severe wheezing across 8 US pediatric ERs, azithromycin showed no ...
People living with HIV (PLWH) face a myriad of risks for comorbidities, including metabolic complications, that extend goal therapeutic outcomes well beyond just maintaining viral ...
Vibrio species are bacteria that live in salt water environments. When ingested orally or though contact with open wounds, some species can cause severe life-threatening infections, particularly in ...
The expanding Gram-negative antibiotic pipeline offers important new treatment options; however, FDA approval alone does not ...
Halkitis, PhD, MS, MPH, dean of Rutgers School of Public Health, has had HIV for nearly 40 years and he brings up a significant point around the time of his diagnosis to the evolution of care and to ...
Salgado is an assistant professor of Pharmacy Practice at the Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, in Brooklyn, NY. She also serves as an ...
The FDA has approved Pfizer-BioNTech's 2026-2027 Comirnaty XFG formula, an updated COVID-19 vaccine targeting the XFG variant, for adults 65 and older and for individuals ages five through 64 with at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results